ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

TO KNOW THE INCIDENCE AND RISK FACTORS CAUSING CATHETER RELATED BLOOD STREAM INFECTIONS IN HAEMODIALYSIS PATIENTS

AUTHORS:

Dr Ambreen Shams, Dr Farkhanda Riaz, Dr Khurram Salim Sheikh

ABSTRACT:

Patients with end-stage renal disease (ESRD) are commonly treated with haemodialysis. Catheter-related bloodstream infections (CRBSI) are significant impediments with a high risk of morbidity and mortality in patients on haemodialysis. Objective: To conclude the CRBSI incidence in patients on haemodialysis. Study Design: A cross-sectional study. Place and Duration: In the Nephrology department of FFH Rawalpindi for six Month duration from June 2018 to Nov 2018. Method: In 100 patients on haemodialysis, we assessed the CRBSI incidence admitted in Nephrology department of FFH Rawalpindi. Data were obtained from patients' medical records. Through blood culture; CRBSI was confirmed. Results: Of the 100 patients on haemodialysis selected for the study, 92 were females and remaining were males. 49.7 ± 11.8 years was the mean age. In (64%) of the subjects has positive blood cultures. The staphylococcus coagulase negative was the most usual organism involved (24%). The utmost usual systemic clinical symptoms were chills and fever (92%), localized erythema (50%) and pussy discharge (30%) from catheter site. The duration of catheter indwelling was less than one year in most patients (74%). Conclusion: Considering high risk of death due to CRBSI in dialysis patients, it is advised that arteriovenous fistula should be made earlier if GFR ˂15. If catheter placement is necessary, pass tunnelled catheter and avoid femoral site. Staff should wear gloves, patient should maintain hygiene and instillation of gentamycin and heparin in catheters post dialysis to avoid infections. Key Words: Catheter-related bloodstream infections, haemodialysis, End-stage renal disease.

FULL TEXT

Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.